The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder (Q46703278)

24 December 2017

title

The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder (English)

1 reference

24 December 2017

obsessive-compulsive disorder

main subject

1 reference

3

Daphna Joel

1 reference

24 December 2017

author name string

Shlomit Flaisher-Grinberg

series ordinal

1

1 reference

24 December 2017

Oded Klavir

series ordinal

2

1 reference

24 December 2017

publication date

14 March 2008

1 reference

24 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

24 December 2017

volume

11

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

811-825

1 reference

24 December 2017

Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

How to treat OCD in patients with Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

The neural basis of addiction: a pathology of motivation and choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

'Compulsive' lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

The signal attenuation rat model of obsessive-compulsive disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Serotonin and drug reward: focus on 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

m-CPP-induced self-grooming is mediated by 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Role of 5-HT in stress, anxiety, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Neuroimaging studies of obsessive-compulsive disorder in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Current concepts in the pharmacological treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Prefrontal serotonin depletion affects reversal learning but not attentional set shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Cognitive inflexibility after prefrontal serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

5-HT2A and 5-HT2C receptors and their atypical regulation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Dissociation of systemic and hippocampal modulation of rat locomotor activity by 5-HT(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

RS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Absorption and brain penetration of a high affinity, highly selective 5-HT2C receptor antagonist, RS-102221.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

5-HT2C receptor agonists as potential drugs for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

5-HT2 receptor subtypes: a family re-united?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Neurobiologic processes in drug reward and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

5-HT2A and 5-HT2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo-pituitary-testicular response to the presence of a female

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

7 January 2021

Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

7 January 2021

Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

7 January 2021

Pharmacotherapy for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

7 January 2021

New developments in obsessive-compulsive disorder research: implications for clinical management.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800847X

7 January 2021

10.1017/S146114570800847X

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017